TFS
EW icon

Thoroughbred Financial Services’s Edwards Lifesciences EW Stock Holding History

Thoroughbred Financial Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
5,144
+14
+0.3% +$1.17K 0.02% 448
2026
Q1 		$410K Hold
5,130
– – 0.02% 435
2025
Q4 		$437K Hold
5,130
– – 0.03% 407
2025
Q3 		$398K Sell
5,130
-17
-0.3% -$1.33K 0.02% 420
2025
Q2 		$402K Sell
5,147
-13,638
-73% -$1.02M 0.03% 404
2025
Q1 		$1.36M Sell
18,785
-760
-4% -$54.4K 0.09% 226
2024
Q4 		$1.45M Buy
19,545
+465
+2% +$32.5K 0.09% 211
2024
Q3 		$1.26M Buy
19,080
+3,746
+24% +$272K 0.08% 232
2024
Q2 		$1.42M Buy
15,334
+9,556
+165% +$846K 0.09% 205
2024
Q1 		$552K Sell
5,778
-10,074
-64% -$846K 0.05% 276
2023
Q4 		$1.21M Sell
15,852
-107
-0.7% -$7.45K 0.1% 201
2023
Q3 		$1.1M Buy
15,959
+7,962
+100% +$640K 0.11% 196
2023
Q2 		$754K Hold
7,997
– – 0.1% 199
2023
Q1 		$661K Sell
7,997
-384
-5% -$30.2K 0.1% 207
2022
Q4 		$625K Sell
8,381
-655
-7% -$50.5K 0.1% 208
2022
Q3 		$746K Sell
9,036
-255
-3% -$24.5K 0.14% 159
2022
Q2 		$883K Hold
9,291
– – 0.16% 152
2022
Q1 		$1.09M Buy
9,291
+7,062
+317% +$792K 0.18% 138
2021
Q4 		$288K Buy
+2,229
New +$260K 0.06% 275
2020
Q2 		– Sell
-10,002
Closed -$629K – 230
2020
Q1 		$629K Buy
10,002
+2,688
+37% +$194K 0.22% 122
2019
Q4 		$569K Buy
7,314
+2,685
+58% +$210K 0.19% 136
2019
Q3 		$339K Buy
4,629
+285
+7% +$20K 0.13% 170
2019
Q2 		$268K Buy
4,344
+435
+11% +$26.3K 0.1% 161
2019
Q1 		$249K Buy
+3,909
New +$223K 0.1% 195

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Thoroughbred Financial Services's EW Position: Q2 2026 in Review

Thoroughbred Financial Services increased its Edwards Lifesciences (EW) stake by 0.27% in Q2 2026, buying an estimated $1.17K and bringing the position to 5,144 shares worth $465K. The position accounts for 0.02% of the portfolio, ranked #448.

Thoroughbred Financial Services first reported a position in EW in Q1 2019 and has held it in 24 quarters since. The position peaked at $1.45M in Q4 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Thoroughbred Financial Services held 5,144 shares of Edwards Lifesciences worth $465K as of Q2 2026.
  • Thoroughbred Financial Services bought 14 Edwards Lifesciences shares in Q2 2026, an estimated $1.17K.
  • Edwards Lifesciences made up 0.02% of Thoroughbred Financial Services's portfolio in Q2 2026, its #448 holding.
  • Thoroughbred Financial Services first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 24 quarters since.
  • Thoroughbred Financial Services's Edwards Lifesciences position peaked at $1.45M in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Thoroughbred Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.